140 related articles for article (PubMed ID: 15507528)
41. Epstein-Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes.
Jin YY; Wang X; Du J; Cao RM; Law HK; Wang JJ; Chen TX
Hum Immunol; 2014 Apr; 75(4):306-16. PubMed ID: 24530751
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
43. Rapamycin Inhibits Expansion of Cord Blood Derived NK and T Cell.
Zare M; Valipour B; Mohammadi SM; Nouri M; Movassaghpour A; Nozad Charoudeh H
Iran J Immunol; 2017 Sep; 14(3):192-199. PubMed ID: 28919582
[TBL] [Abstract][Full Text] [Related]
44. Activation of human T cells with NK cell markers by staphylococcal enterotoxin A via IL-12 but not via IL-18.
Ami K; Ohkawa T; Koike Y; Sato K; Habu Y; Iwai T; Seki S; Hiraide H
Clin Exp Immunol; 2002 Jun; 128(3):453-9. PubMed ID: 12109440
[TBL] [Abstract][Full Text] [Related]
45. Human dendritic cells pulsed with autologous Epstein-Barr virus transformed B-cell lymphoblastoid cell (BCL) lysate elicit a BCL specific MHC-class II restricted T-cell response.
Sugano M; Conway TF; Kelleher RJ; Sugiyama Y; Chen FA; Bankert RB; Bernstein SH
J Exp Clin Cancer Res; 2001 Jun; 20(2):175-82. PubMed ID: 11484971
[TBL] [Abstract][Full Text] [Related]
46. Bone marrow cells promote TH2 polarization and inhibit virus-specific CTL generation.
Jin Y; Fuller L; Wei Y; Blomberg BB; Miller J; Esquenazi V
Hum Immunol; 2000 Dec; 61(12):1233-41. PubMed ID: 11163078
[TBL] [Abstract][Full Text] [Related]
47. Epstein-Barr virus-induced transformation of human B lymphocytes: the effect of L-leucyl-L-leucine methyl ester on inhibitory T cell populations.
Ohlin M; Kristensson K; Carlsson R; Borrebaeck CA
Immunol Lett; 1992 Dec; 34(3):221-8. PubMed ID: 1362566
[TBL] [Abstract][Full Text] [Related]
48. [Ex vivo inducing cultured Epstein-Barr virus specific cytotoxic T lymphocytes and evaluation of their killing effect].
Chen GH; Gu B; Chen F; Wang Y; Qiao M; Liu HW; Feng YF; Dai LJ; Zhu ZL; Wu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1597-601. PubMed ID: 24370055
[TBL] [Abstract][Full Text] [Related]
49. Retrovirus-mediated gene transfer in primary T lymphocytes impairs their anti-Epstein-Barr virus potential through both culture-dependent and selection process-dependent mechanisms.
Sauce D; Bodinier M; Garin M; Petracca B; Tonnelier N; Duperrier A; Melo JV; Apperley JF; Ferrand C; Hervé P; Lang F; Tiberghien P; Robinet E
Blood; 2002 Feb; 99(4):1165-73. PubMed ID: 11830462
[TBL] [Abstract][Full Text] [Related]
50. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
Kariya Y; Inoue N; Kihara T; Okamoto N; Sugie K; Mori T; Uchida A
Immunol Lett; 1992 Feb; 31(3):241-5. PubMed ID: 1372283
[TBL] [Abstract][Full Text] [Related]
51. IL-15 is highly expressed in inflammatory bowel disease and regulates local T cell-dependent cytokine production.
Liu Z; Geboes K; Colpaert S; D'Haens GR; Rutgeerts P; Ceuppens JL
J Immunol; 2000 Apr; 164(7):3608-15. PubMed ID: 10725717
[TBL] [Abstract][Full Text] [Related]
52. CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation.
Nikiforow S; Bottomly K; Miller G
J Virol; 2001 Apr; 75(8):3740-52. PubMed ID: 11264363
[TBL] [Abstract][Full Text] [Related]
53. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
[TBL] [Abstract][Full Text] [Related]
54. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
55. Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation.
York LJ; Qualtiere LF
Viral Immunol; 1990; 3(2):127-36. PubMed ID: 2163257
[TBL] [Abstract][Full Text] [Related]
56. Defective control of Epstein-Barr virus-infected B cell growth in patients with X-linked lymphoproliferative disease.
Yasuda N; Lai PK; Rogers J; Purtlo DT
Clin Exp Immunol; 1991 Jan; 83(1):10-6. PubMed ID: 1846327
[TBL] [Abstract][Full Text] [Related]
57. Specificity of monoclonal antibodies to an EBV transformed B-cell line.
Schröder J; Suomalainen HA; Parkkinen E; Lundqvist C; Wada G; Koskimies S
Med Biol; 1982 Oct; 60(5):255-9. PubMed ID: 6296556
[TBL] [Abstract][Full Text] [Related]
58. Effect of cytokines on proliferation of Epstein Barr virus-transformed B lymphocytes.
Richter W; Eiermann TH; Scherbaum WA
Hybridoma; 1990 Feb; 9(1):1-8. PubMed ID: 2155870
[TBL] [Abstract][Full Text] [Related]
59. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
60. High frequency of Epstein-Barr virus (EBV) lymphoblastoid cell line-reactive lymphocytes in cord blood: evaluation of cytolytic activity and IL-2 production.
Moretta A; Comoli P; Montagna D; Gasparoni A; Percivalle E; Carena I; Revello MG; Gerna G; Mingrat G; Locatelli F; Rondini G; Maccario R
Clin Exp Immunol; 1997 Feb; 107(2):312-20. PubMed ID: 9030869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
